Back to mobile site

Raymond James Starts Dianthus Therapeutics (DNTH) at Outperform, 'Planting a Seed Now for This New Complement Idea'

September 28, 2023 6:26 AM EDT Send to a Friend
(Updated - September 28, 2023 6:26 AM EDT)

Raymond James analyst Steven Seedhouse initiates coverage on Dianthus Therapeutics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login